| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Moonlake Immunotherapeutics (MLTX) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. MLTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 1.99M | $36.69M | - | |
| CFO | 1.28M | $23.48M | - | |
| CEO | 520.3K | $9.57M | - | |
| Other | 520.3K | $9.57M | - | |
| Dir | 21.5K | $395.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2020 | Chen Bihua56 | CEO And Chairman | Buy | 430,000 | $10.00 | $4,300,000.00 | New | |
| Oct 22, 2020 | Helix Holdings LLC | Director, 10% Owner | Buy | 430,000 | $10.00 | $4,300,000.00 | New |